Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

May

11

Exagen Inc. Reports First Quarter 2022 Results

Records in Ordering Healthcare Providers and Adopters, Set All-Time Record for AVISE® CTD Monthly...

11

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing...

1

Exagen Announces Five-Week Campaign for Lupus Awareness Month

Weekly themes to focus on diagnosis, advocacy, community, research, and motivation SAN DIEGO, May 01,...

30

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

AVISE® Lupus and AVISE® CTD tests included in agreement SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE)...

22

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

New partnership will bring total patients with in-network testing benefit to more than 90...

10

Exagen Inc. Reports Third Quarter 2021 Results

Quarterly Records: Ordering Healthcare Providers and Adopters SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:...

27

Exagen Inc. Expands Coverage with Inland Empire Health Plan

Partnership to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus SAN...

9

Exagen Inc. Reports Second Quarter 2021 Results

Quarterly Records: Total Revenue, AVISE® CTD Revenue and Volumes, Ordering Healthcare Providers and Adopters...

13

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

Latest clinical utility study published in Lupus & Science Medicine SAN DIEGO, July 13, 2021 (GLOBE...

11

Exagen Inc. Reports First Quarter 2021 Results

Quarterly Records: AVISE® CTD Volumes, Ordering Healthcare Providers and Adopters SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE)...

4

Exagen Inc., Allegheny Health Network Research Institute, and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests

The suite of innovative biomarker assays seeks to further aid clinicians in the diagnosis,...

3

Exagen Announces New Campaign and Initiatives for Lupus Awareness Month

Joint effort with the Lupus Foundation of America and LupusChick SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE)...